Keywords: watson, offer, 450m, convertible, senior, debentures, pharmaceuticals

Watson to offer $450M convertible senior debentures

Article | 10 March 2003

Watson Pharmaceuticals has said that it plans to offer $450 million ofconvertible senior debentures due 2023, subject to market and other conditions ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Watson Pharmaceuticals

Go to company listing